REYKJAVIK, Iceland and
SANTA CLARITA, CA, Nov. 4, 2019 /PRNewswire/ -- Jon Sigurdsson, President & CEO of Össur and
John Petrovich, CEO of the Alfred
Mann Foundation (AMF) recently signed a milestone agreement that
allows Össur to further develop and license AMF's implanted
myoelectric sensor (IMES®) system as both organizations
continue exploring the potential of mind-controlled prosthetic
technologies.
The IMES® sensors are implanted in muscles that
directly control the desired movement of a bionic prosthetic limb.
The implants sense a small electrical charge in the muscle tissue
and send information wirelessly to the prosthetic limb when the
user intends to make specific movements. As a result, the bionic
limb responds with the desired movement in virtually the same way
that a sound arm, hand or leg would respond.
The world's first-in-man cases to initially evaluate the
IMES® were conducted in 2014 on upper-limb amputees
from the US military, using i-Limb® bionic prosthetic hands
produced by Össur. In 2015, two lower-limb amputees from
Iceland had
IMES® units surgically implanted into their
residual muscle tissue and demonstrated their ability to control
their Össur leg prostheses with their intentions.
As the IMES® system served as a bridge between
the amputee users' neuro-muscular system and their artificial
limbs, the learning process took place subconsciously, continuously
and in real-time for both users. The IMES® system
has also successfully been used in another pilot study to control
an entire bionic arm in amputees who had undergone targeted muscle
re-innervation (TMR) surgery.
"We are eager to further explore how the user-experience
will evolve when amputees use our advanced Bionic prosthetic
solutions along with this advanced sensor technology," said
Jon Sigurdsson, President and CEO of
Össur. "This agreement is another demonstration of our company's
continuing commitment to ongoing research and development in the
field of advanced prosthetics, to help more people enjoy a life
without limitations. Our Bionic products are truly ready to step
into the future," he said.
"We are proud to see our technologies taking a step towards the
market, which is an essential part of our mission," said
John Petrovich, President and CEO of
the Alfred Mann Foundation. "I can think of no better partner to
carry on the future development of the
IMES® system. Össur has the most extensive lineup
of devices capable of using the system, and more importantly they
have the vision to see that mind control will be an important part
of the future of bionic prosthetics."
Contact for ÖSSUR: Laura Jackson
(714)731-6761, lauraminjackson@gmail.com
Contact for ALFRED MANN FOUNDATION: John
Petrovich, (661)702-6807, johnp@aemf.org
This information was brought to you by Cision
http://news.cision.com
https://news.cision.com/ossur-hf-/r/ossur-and-alfred-mann-foundation-sign-new-agreement-to-extend-exploration-of-mind-controlled-prosthe,c2949680
The following files are available for download:
https://mb.cision.com/Main/18404/2949680/1132773.pdf
|
Össur and Alfred Mann
Foundation Sign New Agreement to Extend Exploration of
Mind-Controlled Prosthetics
|
https://news.cision.com/ossur-hf-/i/ossur-logo-2014-tagline,c2710327
|
Ossur Logo
2014-tagline
|
https://news.cision.com/ossur-hf-/i/amf-logo-color-rgb,c2710328
|
AMF-Logo Color
RGB
|
View original
content:http://www.prnewswire.com/news-releases/ossur-and-alfred-mann-foundation-sign-new-agreement-to-extend-exploration-of-mind-controlled-prosthetics-300950518.html
SOURCE Össur hf